Timeline
Cytospire Therapeutics
London oncology biotech; first-in-class T cell engager drug for solid tumours; £61m Series A May 2026.
4 of 4 entries (4 events, 0 interactions)
Filters
#11 9 Jul
Mentioned in: Alchemab wins Bank's record £25m cheque
UK Startups and Innovation#7 2 Jun
Mentioned in: IMU raises £40m to read blood
UK Startups and Innovation#5 14 May
Mentioned in: Lansdowne hits €128.9m on BBB-anchored fund
UK Startups and Innovation#4 5 May